Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
38.79
+0.17 (0.44%)
At close: Jul 19, 2024, 12:00 AM
39.01
+0.22 (0.57%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

CALT Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018
Net Income
-466.19-466.19-412.27-500.29-433.49-32.58
Upgrade
Other Operating Activities
31.5331.53100.9138.71124.31-38.43
Upgrade
Operating Cash Flow
-434.66-434.66-311.35-461.59-309.18-71.01
Upgrade
Capital Expenditures
-12.79-12.79-2.51-6.590-0.12
Upgrade
Acquisitions
0000-172.60
Upgrade
Change in Investments
-0.96-0.96-2.63-1.69-0.01-1.89
Upgrade
Other Investing Activities
000-16.07--16.07
Upgrade
Investing Cash Flow
-13.75-13.75-5.14-24.34-172.61-18.07
Upgrade
Share Issuance / Repurchase
000324795.45197.65
Upgrade
Debt Issued / Paid
226.28226.28482.13193.95-3.97-1.65
Upgrade
Other Financing Activities
-26.63-26.6393.86-82.79-22.922.83
Upgrade
Financing Cash Flow
199.65199.65575.99435.16768.56198.84
Upgrade
Net Cash Flow
-248.75-248.75259.49-50.77286.77109.75
Upgrade
Free Cash Flow
-447.44-447.44-313.87-468.18-309.18-71.13
Upgrade
Free Cash Flow Margin
-37.07%-37.07%-39.09%-204.13%-35375.40%-38.48%
Upgrade
Free Cash Flow Per Share
-15.02-15.02-10.62-18.75-13.36-3.07
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).